SDH deficiency reduces prolyl hydroxylases and hydroxylation of hypoxia-inducible factor-α, resulting in activation of the hypoxia pathway, angiogenesis, glucose metabolism, cell motility and cancer cells survival 24,25. The gene discussed is SDHB; the disease is cancer.